4-[6-甲氧基-2-(4-甲氧基苯基)苯并呋喃-3-羰基]苄腈
![4-[6-甲氧基-2-(4-甲氧基苯基)苯并呋喃-3-羰基]苄腈结构式](https://image.chemsrc.com/caspic/451/176977-56-3.png)
4-[6-甲氧基-2-(4-甲氧基苯基)苯并呋喃-3-羰基]苄腈结构式
|
常用名 | 4-[6-甲氧基-2-(4-甲氧基苯基)苯并呋喃-3-羰基]苄腈 | 英文名 | LY320135 |
|---|---|---|---|---|
| CAS号 | 176977-56-3 | 分子量 | 383.39600 | |
| 密度 | 1.31g/cm3 | 沸点 | 617.2ºC at 760mmHg | |
| 分子式 | C24H17NO4 | 熔点 | N/A | |
| MSDS | 中文版 美版 | 闪点 | 327.1ºC | |
| 符号 |
GHS06 |
信号词 | Danger |
|
Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor.
Mol. Pharmacol. 88 , 368-79, (2015) CB1 cannabinoid receptors (CB1Rs) are attractive therapeutic targets for numerous central nervous system disorders. However, clinical application of cannabinoid ligands has been hampered owing to their adverse on-target effects. Ligand-biased signaling from, ... |
期刊文献综述：
更多...